Medical Foods Market Size is Predicted to Witness 5.1% CAGR till 2030

[sara James]

The global Medical Foods Market size is anticipated to reach USD 33.4 billion by 2030, growing at a CAGR of 5.1% during the forecast period, according to a new report by Grand View Research, Inc. Rising geriatric population, prevalence of chronic diseases, a shift toward consuming disease-specific formulas, and a growing demand for neonatal and preterm enteral feeding are some of the factors driving this growth.

The oral route of the administration segment dominated the market in 2023. The major factors contributing to this growth include a high preference for oral medical foods owing to the ease of consumption and high commercial viability of products administered orally. In addition, these foods are available in a variety of forms such as pills, powder, puddings, and pre-thickened products, thereby fueling the segment’s growth.

In 2023, the powder product segment accounted for the largest revenue share. Factors contributing to the growth include the rising application areas of powdered medical foods, ease of administration, and higher commercial viability. The liquid segment is anticipated to grow at the fastest CAGR from 2024 to 2030, owing to the ease of consumption of liquid-based foods for special medical purposes by the pediatric and geriatric population.

The chemotherapy-induced diarrhea emerged as the largest application segment in 2023. Diarrhea caused by chemotherapy treatment is one of the common problems among cancer patients and the rising prevalence of cancer is one of the major reasons for this increasing the revenue share. For instance, according to the National Cancer Institute statistics, about half of the patients develop diarrhea when treated with chemotherapy agents and the rate can reach 80% with respect to certain chemotherapy agents.

The institutional sales channel segment dominated the market in 2023. Higher penetration and adoption of oral and enteral medical foods in the healthcare institutions such as clinics, hospitals, and care centers and the rising consumption of these products are some of the major factors contributing to the large revenue share. In addition, the rising demand for such products in inpatient facilities and increasing adoption for such products are boosting the market growth.

North America dominated the market with a revenue share of approximately 30% in 2023.. The presence of major players and high revenue generated by them in the region are the key factors contributing to this growth. In addition, strategic developments, the growing prevalence of chronic conditions, and the increasing adoption of medical foods by patients and healthcare professionals are the other factors supporting the growth.

Related Press Release@ Medical Foods Market Report

Medical Foods Market Report Highlights

• The oral route of the administration segment dominated the market in 2023
• The powder product segment accounted for the largest revenue share in 2023
• Chemotherapy-induced diarrhea emerged as the leading application segment in 2023
• The institutional sales channel segment held the largest revenue share in 2023
• In 2023, North America held the largest revenue share, due to the increasing prevalence of chronic diseases and the presence of key players
• Key players in the medical foods industry are driving growth through strategies like collaborations, acquisitions, and product launches. For instance, in May 2022, Nestlé Health Science acquired a premium Brazilian health and nutrition lifestyle brand, Puravida. This acquisition aims to expand Nestlé's customer base in Brazil.

Medical Foods Market Segmentation

Grand View Research has segmented the global medical foods market based on route of administration, product, application, sales channel, and region:

Medical Foods Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral
• Enteral

Medical Foods Product Outlook (Revenue, USD Million, 2018 - 2030)

• Powder
• Pills
• Liquid
• Other

Medical Foods Application Outlook (Revenue, USD Million, 2018 - 2030)

• Chronic Kidney Disease
• Minimal Hepatic Encephalopathy
• Chemotherapy-induced Diarrhea
• Pathogen Related Infections
• Diabetic Neuropathy
• ADHD
• Depression
• Alzheimer's Disease
• Nutritional Deficiency
• Orphan Diseases
• • Phenylketonuria
  • Eosinophilic Esophagitis
  • FPIES
  • MSUD
  • Homocystinuria
  • Tyrosinemia
  • Others
• Wound Healing
• Chronic Diarrhea
• Constipation Relief
• Protein Booster
• Dysphagia
• Pain Management
• Parkinson's Disease
• Epilepsy
• Other Cancer Related Treatments
• Severe Protein Allergy
• Cachexia
• Other

Medical Foods Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Online Sales
• Retail Sales
• Institutional Sales

Medical Foods Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• • U.S
  • Canada
• Europe
• • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
• • China
  • Japan
  • India
  • South Korea
  • Australia
• Latin America
• • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
• • Saudi Arabia
  • UAE
  • South Africa
  • Kuwait
  • Qatar